Approvals/TGA/SIFROL ER pramipexole dihydrochloride monohydrate 2.25 mg extended-release tablet blister pack

Approved

STANDARD

SIFROL ER pramipexole dihydrochloride monohydrate 2.25 mg extended-release tablet blister pack

Boehringer Ingelheim Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 39a4f9bb6d2bb722
Product Name: SIFROL ER pramipexole dihydrochloride monohydrate 2.25 mg extended-release tablet blister pack
Artg Id: 173901
Artg Name: SIFROL ER pramipexole dihydrochloride monohydrate 2.25 mg extended-release tablet blister pack
Sponsor: Boehringer Ingelheim Pty Ltd
Company Detail Path: /organization/boehringer-ingelheim-pty-ltd
Artg Date: 2011-03-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/f74a609452c977620381f73298baf149.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/d5e484834e19ec2a9764f84ec5d9b3d1.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

39a4f9bb6d2bb722

Type

Standard